Table 2b.
Quality assessment of the included case-control study.
| No | The Joanna Briggs Institute checklist question | Cai et al., 2020 |
|---|---|---|
| 1 | Were the groups comparable other than the presence of disease in cases or the absence of disease in controls? | Y |
| 2 | Were cases and controls matched appropriately? | Y |
| 3 | Were the same criteria used for identification of cases and controls? | Y |
| 4 | Was exposure measured in a standard, valid and reliable way? | Y |
| 5 | Was exposure measured in the same way for cases and controls? | Y |
| 6 | Were confounding factors identified? | N |
| 7 | Were strategies to deal with confounding factors stated? | N |
| 8 | Were outcomes assessed in a standard, valid and reliable way for cases and controls? | Y |
| 9 | Was the exposure period of interest long enough to be meaningful? | Y |
| 10 | Was appropriate statistical analysis used? | Y |
| Overall Appraisal | Include: 8 | |
| Exclude: 2 | ||
| Level of evidence | Level 3.d – Case – controlled study |
Yes= 1, No = 0.